Changeflow GovPing Pharma & Drug Safety Fused Ring STAT6 Inhibitor for Atopic Dermatiti...
Routine Notice Added Final

Fused Ring STAT6 Inhibitor for Atopic Dermatitis Treatment

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO published patent application US20260092054A1 disclosing a fused ring compound with STAT6 inhibitory activity for treating atopic dermatitis and allergic diseases. Invented by Yoshitake Sumikawa, Issei Akahoshi, and Masaya Kato, the application (No. 19116232) was filed September 29, 2023 and published April 2, 2026. The claimed compound and pharmaceutical compositions target inflammatory conditions via STAT6 pathway inhibition.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO published patent application US20260092054A1 claiming a novel fused ring compound expressed by general formula (I) having STAT6 inhibitory activity, along with pharmaceutical compositions containing the compound for treating inflammatory diseases such as atopic dermatitis and allergic diseases. The application includes CPC classifications covering various heterocyclic compound classes (C07D 413/10, C07D 471/04, C07D 487/04) and multiple A61K therapeutic use categories.

Patent application publications are informational notices and do not create immediate compliance obligations or regulatory deadlines. Pharmaceutical companies and researchers monitoring inflammatory disease therapeutics may review the disclosed compound structure and claims for competitive intelligence purposes. No action is required as this is not an issued patent or regulatory requirement.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

FUSED RING COMPOUND AND PHARMACEUTICAL CONTAINING SAME

Application US20260092054A1 Kind: A1 Apr 02, 2026

Inventors

Yoshitake SUMIKAWA, Issei AKAHOSHI, Masaya KATO

Abstract

The present invention provides a novel compound that has STAT6 inhibitory activity and is effective for treatment of inflammatory diseases such as atopic dermatitis and for allergic diseases. A compound pharmaceutically acceptable salt thereof expressed by general formula (I) having STAT6 inhibitory activity.

CPC Classifications

C07D 413/10 A61K 31/404 A61K 31/4184 A61K 31/4192 A61K 31/4196 A61K 31/4245 A61K 31/427 A61K 31/433 A61K 31/437 A61K 31/4439 A61K 31/444 A61K 31/454 A61K 31/4725 A61K 31/501 A61K 31/513 A61K 31/519 A61K 31/5377 A61K 31/635 C07D 209/22 C07D 235/18 C07D 401/04 C07D 401/10 C07D 401/14 C07D 403/04 C07D 403/10 C07D 403/14 C07D 405/04 C07D 417/14 C07D 471/04 C07D 487/04

Filing Date

2023-09-29

Application No.

19116232

View original document →

Named provisions

Abstract CPC Classifications Inventors Filing Date Application No.

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260092054A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers Patients
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Pharmaceutical Patents
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!